{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:57:14Z","timestamp":1793105834476,"version":"4.5.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01400","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:29:58Z","timestamp":1543537798000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Effect of Ninjin\u2019yoeito on the Loss of Skeletal Muscle Function in Cancer-Bearing Mice"],"prefix":"10.3389","volume":"9","author":[{"given":"Masahiro","family":"Ohsawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Maruoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Inami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei-ichiro","family":"Ishikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.24784","article-title":"Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice.","volume":"126","author":"Asp","year":"2010","journal-title":"Int. J. Cancer"},{"key":"B2","author":"Bensky","year":"2004","journal-title":"Chinese Herbal Medicine: Materia Medica"},{"key":"B3","doi-asserted-by":"publisher","first-page":"23977","DOI":"10.1074\/jbc.C200171200","article-title":"AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.","volume":"277","author":"Bolster","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"},{"key":"B5","first-page":"2359","article-title":"Uncomplicated starvation versus cancer cachexia.","volume":"37","author":"Brennan","year":"1977","journal-title":"Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-15-0533","article-title":"Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.","volume":"229","author":"Cleasby","year":"2016","journal-title":"J. Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1123S","DOI":"10.3945\/ajcn.2010.28608A","article-title":"Skeletal muscle loss: cachexia, sarcopenia, and inactivity.","volume":"91","author":"Evans","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways.","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype.","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1126\/science.1542794","article-title":"The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.","volume":"255","author":"Gearing","year":"1992","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ctim.2015.03.002","article-title":"Use of traditional Chinese medicine (Ren Shen Yang Rong Tang) against microinflammation in hemodialysis patients: an open-label trial.","volume":"23","author":"Hsiao","year":"2015","journal-title":"Complement. Ther. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.2337\/diabetes.52.11.2784","article-title":"Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice.","volume":"52","author":"Klover","year":"2003","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jphs.2017.05.010","article-title":"Role of microglia in mechanical allodynia in the anterior cingulate cortex.","volume":"134","author":"Miyamoto","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1271\/bbb.70057","article-title":"AMPK activation stimulates myofibrillar protein degradation and expression of atrophy-related ubiquitin ligases by increasing FOXO transcription factors in C2C12 myotubes.","volume":"71","author":"Nakashima","year":"2007","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.1167571","article-title":"Cell signaling. Fat stress and liver resistance.","volume":"322","author":"Ogawa","year":"2008","journal-title":"Science"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-7-85","article-title":"The dipeptide Phe-Phe amide attenuates signs of hyperalgesia, allodynia and nociception in diabetic mice using a mechanism involving the sigma receptor system.","volume":"7","author":"Ohsawa","year":"2011","journal-title":"Mol. Pain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","article-title":"Mechanisms of cancer cachexia.","volume":"89","author":"Tisdale","year":"2009","journal-title":"Physiol. Rev."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the ApcMin\/+ mouse.","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"E1042","DOI":"10.1152\/ajpendo.00410.2012","article-title":"Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.","volume":"304","author":"White","year":"2013","journal-title":"AJP Endocrinol. Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cger.2010.08.009","article-title":"The frailty syndrome: definition and natural history.","volume":"27","author":"Xue","year":"2011","journal-title":"Clin. Geriatr. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:29:59Z","timestamp":1543537799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":20,"alternative-id":["10.3389\/fphar.2018.01400"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01400","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"article-number":"1400"}}